Novartis Pharma AG
FDA inspection history in Basel, Switzerland, 2022
- 1
- Form 483
Every document, by year
- Form 483
2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at Basel, Switzerland.
Cited most
Across all Novartis Pharma AG observations on file
- 21 CFR 211.68Automatic, mechanical, and electronic equipment2
- 21 CFR 211.170Reserve samples1
The complete Novartis Pharma AG file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Basel, Switzerland
One Form 483 · 2022 · 3 observations
Latest: Form 483, Aug 30, 2022 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-08-30 | 483 Form 483 | Basel, Switzerland | 3 | $99 |
Investigators on these documents
FEI number 3002807772 · most recent document Aug 30, 2022
About Novartis Pharma AG
How many FDA Form 483s has Novartis Pharma AG received?
FDA Intel has 1 Form 483 on file for Novartis Pharma AG; the most recent is dated Aug 30, 2022.
When was Novartis Pharma AG last inspected by FDA?
The most recent FDA inspection document on file for Novartis Pharma AG is a Form 483 dated Aug 30, 2022, for the site in Basel, Switzerland.
What did FDA cite at Novartis Pharma AG?
The regulations cited most in the observations on file for Novartis Pharma AG are 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 2 times; 21 CFR 211.170 (Reserve samples), 1 time.